Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Milton S. Hershey Medical Center
Institut Bergonié
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Teva Branded Pharmaceutical Products R&D, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Novartis
Bristol-Myers Squibb